Valerian: No evidence for clinically relevant interactions

Evidence-based Complementary and Alternative Medicine

Volumn 2014, Issue , 2014, Pages

  Kelber, Olaf ^a,b   Nieber, Karen ^a,c   Kraft, Karin ^a,d  

^a Kooperation Phytopharmaka   (Germany)

^b Steigerwald Arzneimittelwerk GmbH   (Germany)

^c UNIVERSITY OF LEIPZIG   (Germany)

^d ROSTOCK UNIVERSITY MEDICAL CENTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA HYDROXYMIDAZOLAM; ALPRAZOLAM; BENZODIAZEPINE DERIVATIVE; CITALOPRAM; CODEINE; CYTOCHROME P450 1A2; CYTOCHROME P450 2D6; CYTOCHROME P450 2E1; CYTOCHROME P450 3A4; DEXTROMETHORPHAN; DEXTRORPHAN; HALOPERIDOL; ISOENZYME; LOPERAMIDE; LORAZEPAM; MIDAZOLAM; MULTIDRUG RESISTANCE PROTEIN; PROPRANOLOL; VALERIAN;

CONTROLLED CLINICAL TRIAL (TOPIC); DELIRIUM; DRUG EFFICACY; DRUG SAFETY; DRUG SURVEILLANCE PROGRAM; HERB DRUG INTERACTION; HUMAN; IC 50; IN VITRO STUDY; INSOMNIA; MEMORY DISORDER; META ANALYSIS (TOPIC); NONHUMAN; REBOUND; RESPIRATION DEPRESSION; REVIEW; SINGLE DRUG DOSE; SYSTEMATIC REVIEW; VALERIANA OFFICINALIS;

EID: 84904673496     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2014/879396     Document Type: Review

References (60)

1. Sloan Kettering Center, Integrative Medicine-Valerian. 2012, http://www.mskcc.org/cancer-care/herb/valerian
2. Sparreboom A., Baker S. D., Abrams D., Weil A. T., CAM-Chemo interactions-what is known? Integrative Oncology 2009 8 New York, NY, USA Oxford University Press 171 194 Weil Integrative Medicine Library
3. Deutsche Krebshilfe e.V.,. 2014, http://www.krebshilfe.de
4. Donaldson M., Touger-Decker R., Dietary supplement interactions with medications used commonly in dentistry. Journal of the American Dental Association 2013 144 7 787 794 2-s2.0-84881110051
5. Block K. I., Gyllenhaal C., Mead M. N., Safety and efficacy of herbal sedatives in cancer care. Integrative Cancer Therapies 2004 3 2 128 148 2-s2.0-2442680397 10.1177/1534735404265003 (Pubitemid 38669045)
6. Hossain J. L., Shapiro C. M., The prevalence, cost implications, and management of sleep disorders: an overview. Sleep and Breathing 2002 6 2 85 102 2-s2.0-0036302301 10.1007/s11325-002-0085-1 (Pubitemid 34752701)
7. Kessler R. C., Berglund P. A., Coulouvrat C., Fitzgerald T., Hajak G., Roth T., Shahly V., Shillington A. C., Stephenson J. J., Walsh J. K., Insomnia, comorbidity, and risk of injury among insured Americans: results from the America insomnia survey. Sleep 2012 35 6 825 834 2-s2.0-84861906538 10.5665/sleep.1884
8. Ohayon M., Epidemiological study on insomnia in the general population. Sleep 1996 19 supplement 3 S7 S15 2-s2.0-0029871043
9. Shapiro C. M., Dement W. C., Shapiro C. M., Impact and epidemiology of sleep disorders. ABC of Sleep Disorders 1993 London, UK BMJ 1 5
10. Kamel N. S., Gammack J. K., Insomnia in the elderly: cause, approach, and treatment. The American Journal of Medicine 2006 119 6 463 469 2-s2.0-33646923436 10.1016/j.amjmed.2005.10.051 (Pubitemid 43795168)
11. National Institute of Health, NIH state-of-the-science conference statement on manifestations and management of chronic insomnia in adults. NIH Consensus and State-of-the-Science Statements 2005 22 2 1 30
12. Tariq S. H., Pulisetty S., Pharmacotherapy for insomnia. Clinics in Geriatric Medicine 2008 24 1 93 105 2-s2.0-38949147202 10.1016/j.cger.2007.08. 009 (Pubitemid 351491174)
13. Houghton P. J., The scientific basis for the reputed activity of Valerian. Journal of Pharmacy and Pharmacology 1999 51 5 505 512 2-s2.0-0033063823 10.1211/0022357991772772 (Pubitemid 29319774)
14. Hadley S., Petry J. J., Valerian. American Family Physician 2003 67 8 1755 1758 2-s2.0-0037447558 (Pubitemid 36512817)
15. Navarrete A., Avula B., Choi Y., Khan I. A., Chemical fingerprinting of Valeriana species: simultaneous determination of valerenic acids, flavonoids, and phenylpropanoids using liquid chromatography with ultraviolet detection. Journal of AOAC International 2006 89 1 8 15 2-s2.0-33646853535 (Pubitemid 44943381)
16. Fernandez-San-Martin M. I., Masa-Font R., Palacios-Soler L., Sancho-Gomez P., Calbo-Caldentey C., Flores-Mateo G., Effectiveness of Valerian on insomnia: a meta-analysis of randomized placebo-controlled trials. Sleep Medicine 2010 11 6 505 511 2-s2.0-77953360048 10.1016/j.sleep.2009.12.009
17. Barton D. L., Atherton P. J., Bauer B. A., Moore D. F. Jr., Mattar B. I., Lavasseur B. I., Rowland K. M. Jr., Zon R. T., Lelindqwister N. A., Nagargoje G. G., Morgenthaler T. I., Sloan J. A., Loprinzi C. L., The use of Valeriana officinalis (Valerian) in improving sleep in patients who are undergoing treatment for cancer: a phase III randomized, placebo-controlled, double-blind study (NCCTG Trial, N01C5). Journal of Supportive Oncology 2011 9 1 24 31 2-s2.0-79955975748 10.1016/j.suponc.2010.12.008
18. Community Herbal Monograph on Valeriana officinalis L., Radix 2007 EMA
19. Gerhard U., Linnenbrink N., Georghiadou C., Hobi V., Vigilanzmindernde effekte zweier pflanzlicher schlafmittel. Rundschau für Medizin 1996 85 15 473 481 2-s2.0-0029965478 (Pubitemid 26126342)
20. Glass J. R., Sproule B. A., Herrmann N., Streiner D., Busto U. E., Acute pharmacological effects of Temazepam, Dsiphenhydramine, and Valerian in healthy elderly subjects. Journal of Clinical Psychopharmacology 2003 23 3 260 268 2-s2.0-0038384131 10.1097/00004714-200306000-00007 (Pubitemid 36807793)
21. Gutierrez S., Ang-Lee M. K., Walker D. J., Zacny J. P., Assessing subjective and psychomotor effects of the herbal medication Valerian in healthy volunteers. Pharmacology Biochemistry and Behavior 2004 78 1 57 64 2-s2.0-2442639941 10.1016/j.pbb.2004.02.011 (Pubitemid 38670513)
22. Hallam K. T., Olver J. S., McGrath C., Norman T. R., Comparative cognitive and psychomotor effects of single doses of Valeriana officianalis and triazolam in healthy volunteers. Human Psychopharmacology 2003 18 8 619 625 2-s2.0-0346339683 10.1002/hup.542 (Pubitemid 38028788)
23. Kuhlmann J., Berger W., Podzuweit H., Schmidt U., The influence of Valerian treatment on "reaction time, alertness and concentration" in volunteers. Pharmacopsychiatry 1999 32 6 235 241 2-s2.0-0032735879
24. Garges H. P., Varia I., Doraiswamy P. M., Cardiac complications and delirium associated with Valerian root withdrawal. Journal of the American Medical Association 1998 280 18 1566 1567 2-s2.0-0032508880 (Pubitemid 28520640)
25. Ang-Lee M. K., Moss J., Yuan C. S., Herbal medicines and perioperative care. Journal of the American Medical Association 2001 286 2 208 216 2-s2.0-0034945280 (Pubitemid 32640852)
26. Abebe W., Herbal medication: potential for adverse interactions with analgesic drugs. Journal of Clinical Pharmacy and Therapeutics 2002 27 6 391 401 2-s2.0-0036458013 10.1046/j.1365-2710.2002.00444.x (Pubitemid 35469171)
27. Izzo A. A., Interactions between herbs and conventional drugs: overview of the clinical data. Medical Principles and Practice 2012 21 5 404 428 2-s2.0-84865010199 10.1159/000334488
28. Taibi D. M., Landis C. A., Petry H., Vitiello M. V., A systematic review of Valerian as a sleep aid: safe but not effective. Sleep Medicine Reviews 2007 11 3 209 230 2-s2.0-34248544974 10.1016/j.smrv.2007.03.002 (Pubitemid 46756375)
29. Plushner S. L., Valerian: Valeriana officinalis. American Journal of Health-System Pharmacy 2000 57 4 328 335 2-s2.0-0343851571
30. Steinhoff B., Current perspectives on herb-drug interactions in the European regulatory landscape. Planta Medica 2012 78 13 1416 1420 2-s2.0-84866118516 10.1055/s-0032-1314939
31. Wheatley D., Medicinal plants for insomnia: a review of their pharmacology, efficacy and tolerability. Journal of Psychopharmacology 2005 19 4 414 421 2-s2.0-22344442003 10.1177/0269881105053309 (Pubitemid 41003139)
32. Office of Dietary Supplements at the NIH, Factsheet Valerian. 2012, http://ods.od.nih.gov/factsheets/Valerian-HealthProfessional
33. MedIQ-Datenbank, 2014, http://www.mediq.ch
34. Yokotani K., Chiba T., Sato Y., Nakanishi T., Murata M., Umegaxj K., Effect of three herbal extracts on cytochrome P450 and possibility of interaction with drugs. Shokuhin Eiseigaku Zasshi 2013 54 1 56 64 2-s2.0-84875754830 10.3358/shokueishi.54.56
35. Gurley B. J., Gardner S. F., Hubbard M. A., Williams D. K., Gentry W. B., Khan I. A., Shah A., In vivo effects of goldenseal, kava kava, black cohosh, and Valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 phenotypes. Clinical Pharmacology and Therapeutics 2005 77 5 415 426 2-s2.0-19144363905 10.1016/j.clpt.2005.01.009 (Pubitemid 40719269)
36. Hellum B. H., Hu Z., Nilsen O. G., The induction of CYP1A2, CYP2D6 and CYP3A4 by six trade herbal products in cultured primary human hepatocytes. Basic and Clinical Pharmacology and Toxicology 2007 100 1 23 30 2-s2.0-33845996201 10.1111/j.1742-7843.2007.00011.x (Pubitemid 46051439)
37. Donovan J. L., DeVane C. L., Chavin K. D., Wang J., Gibson B. B., Gefroh H. A., Markowitz J. S., Multiple night-time doses of Valerian (Valeriana officinalis) had minimal effects on CYP3A4 activity and no effect on CYP2D6 activity in healthy volunteers. Drug Metabolism and Disposition 2004 32 12 1333 1336 2-s2.0-9444277298 10.1124/dmd.104.001164 (Pubitemid 39564550)
38. Budzinski J. W., Foster B. C., Vandenhoek S., Arnason J. T., An in vitro evaluation of human cytochrome P450 3A4 inhibition by selected commercial herbal extracts and tinctures. Phytomedicine 2000 7 4 273 282 2-s2.0-0033868271 (Pubitemid 30618491)
39. Lefebvre T., Foster B. C., Drouin C. E., Krantis A., Arnason J. T., Livesey J. F., Jordan S. A., In vitro of commercial Valerian root extracts against human cytochrome P450 3A4. Journal of Pharmacy and Pharmaceutical Sciences 2004 7 2 265 273 2-s2.0-11244253059 (Pubitemid 41528901)
40. Hellum B. H., Nilsen O. G., In vitro inhibition of CYP3A4 metabolism and P-glycoprotein-mediated transport by trade herbal products. Basic and Clinical Pharmacology and Toxicology 2008 102 5 466 475 2-s2.0-42149119034 10.1111/j.1742-7843.2008.00227.x (Pubitemid 351537792)
41. Alkharfy K. M., Frye R. F., Effect of Valerian, Valerian/hops extracts, and valerenic acid on glucuronidation in vitro. Xenobiotica 2007 37 2 113 123 2-s2.0-33847081268 10.1080/00498250601050420
42. Mohamed M. F., Tseng T., Frye R. F., Inhibitory effects of commonly used herbal extracts on UGT1A1 enzyme activity. Xenobiotica 2010 40 10 663 669 2-s2.0-77956575028 10.3109/00498254.2010.505669
43. Mozayani A., Raymon L., Handbook of Drug Interactions: A Clinical and Forensic Guide 2012 2nd New York, NY, USA Humana Press
44. Bachmann K. A., Lewis J. D., Predicting inhibitory drug-drug interactions and evaluating drug interaction reports using inhibition constants. Annals of Pharmacotherapy 2005 39 6 1064 1072 2-s2.0-18844410849 10.1345/aph.1E508 (Pubitemid 40695974)
45. Markowitz J. S., Zhu H. J., Limitations of in vitro assessments of the drug interaction potential of botanical supplements. Planta Medica 2012 78 13 1421 1427 2-s2.0-84866082324 10.1055/s-0032-1315025
46. Hellum B. H., Nilsen O. G., The in vitro inhibitory potential of trade herbal products on human CYP2D6-mediated metabolism and the influence of ethanol. Basic and Clinical Pharmacology and Toxicology 2007 101 5 350 358 2-s2.0-34848906016 10.1111/j.1742-7843.2007.00121.x (Pubitemid 47512382)
47. Hellum B. H., Hu Z., Nilsen O. G., Tradeherbal products and induction of cyp2c19 and cyp2e1 in cultured human hepatocytes. Basic and Clinical Pharmacology and Toxicology 2009 105 1 58 63 2-s2.0-67651208865 10.1111/j.1742-7843.2009.00412.x
48. Mohamed M. F., Frye R. F., Effects of herbal supplements on drug glucuronidation. Review of clinical, animal, and in vitro studies. Planta Medica 2011 77 4 311 321 2-s2.0-79952479196 10.1055/s-0030-1250457
49. Trauner G., Khom S., Baburin I., Benedek B., Hering S., Kopp B., Modulation of GABAA receptors by Valerian extracts is related to the content of valerenic acid. Planta Medica 2008 74 1 19 24 2-s2.0-39149114366 10.1055/s-2007-993761 (Pubitemid 351251378)
50. Khom S., Baburin I., Timin E., Hohaus A., Trauner G., Kopp B., Hering S., Valerenic acid potentiates and inhibits GABAA receptors: molecular mechanism and subunit specificity. Neuropharmacology 2007 53 1 178 187 2-s2.0-34547229341 10.1016/j.neuropharm.2007.04.018 (Pubitemid 47125958)
51. Dalla Corte C. L., Fachinetto R., Colle D., Pereira R. P., Ávila D. S., Villarinho J. G., Wagner C., Pereira M. E., Nogueira C. W., Soares F. A. A., Rocha J. B. T., Potentially adverse interactions between haloperidol and Valerian. Food and Chemical Toxicology 2008 46 7 2369 2375 2-s2.0-44749087057 10.1016/j.fct.2008.03.019
52. Fachinetto R., Villarinho J. G., Wagner C., Pereira R. P., Avila D. S., Burger M. E., Calixto J. B., Rocha J. B. T., Ferreira J., Valeriana officinalis does not alter the orofacial dyskinesia induced by haloperidol in rats: role of dopamine transporter. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2007 31 7 1478 1486 2-s2.0-34548143367 10.1016/j.pnpbp.2007.06.028 (Pubitemid 47302567)
53. Bhatt C., Kanaki N., Nayak R., Shah G., Synergistic potentiation of anti-anxiety activity of Valerian and alprazolam by liquorice. Indian Journal of Pharmacology 2013 45 2 202 203 2-s2.0-84875969180 10.4103/0253-7613.108328
54. Kohnen R., Oswald W.-D., The effects of Valerian, propranolol, and their combination on activation, performance, and mood of healthy volunteers under social stress conditions. Pharmacopsychiatry 1988 21 6 447 448 2-s2.0-0024272546 (Pubitemid 19024221)
55. Carrasco M. C., Vallejo J. R., Pardo-de-Santayana M., Peral D., Martin M. A., Altimiras J., Interactions of Valeriana officinalis L. and Passiflora incarnata L. in a patient treated with lorazepam. Phytotherapy Research 2009 23 12 1795 1796 2-s2.0-73449137231 10.1002/ptr.2847
56. Khawaja I. S., Marotta R. F., Lippmann S., Herbal medicines as a factor in delirium. Psychiatric Services 1999 50 7 969 970 2-s2.0-0033057685
57. Unger M., Pharmakokinetische arzneimittelinteraktionen durch pflanzliche arzneimittel. Wiener Medizinische Wochenschrift 2010 160 21-22 571 577 2-s2.0-78651388913 10.1007/s10354-010-0848-4
58. Block K. I., Gyllenhaal C., Clinical corner: herb-drug interactions in cancer chemotherapy: theoretical concerns regarding drug metabolizing enzymes. Integrative Cancer Therapies 2002 1 1 83 89 2-s2.0-0041761331 10.1177/1534735402001001007 (Pubitemid 37101542)
59. Paoletti A., Gallo E., Benemei S., Vietri M., Lapi F., Volpi R., Menniti-Ippolito F., Gori L., Mugelli A., Firenzuoli F., Interactions between natural health products and oral anticoagulants: spontaneous reports in the Italian surveillance system of natural health products. Evidence-Based Complementary and Alternative Medicine 2011 2011 5 2-s2.0-79952176479 10.1155/2011/612150 612150
60. Nowack R., Balle C., Birnkammer F., Koch W., Sessler R., Birck R., Impact of food and herbal medication on calcineurin inhibitor dose in renal transplant patients: a cross-sectional study. Journal of Medicinal Food 2011 14 7-8 756 760 2-s2.0-79960458306 10.1089/jmf.2010.0163